Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1AKris M. White, Adolfo García‐Sastre, Soner Yildiz et al.|Science|2021Cited by 364
Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product PlitidepsinAlejandro Losada, Carlos M. Galmarini|Scientific Reports|2016Cited by 95
Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survivalAlejandro Losada, Carlos M. Galmarini|British Journal of Cancer|2018Cited by 39
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™Alejandro Losada, Luis García‐Fernández|British Journal of Cancer|2004Cited by 26
Plitidepsin as an Immunomodulator against Respiratory Viral InfectionsAlejandro Losada, Adolfo García‐Sastre|The Journal of Immunology|2024Cited by 6